Occulomotor Neural Integrator Dysfunction in Multiple Sclerosis: Insights From Neuroimaging.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

1. Longitudinal tract-based spatial statistics analysis of white matter diffusivity changes and cognitive decline during the transition from MCI to Alzheimer's disease.PloS one · 2025
   Article
2. System-level hypothesis of dopamine imbalance in early multiple sclerosis.Frontiers in neurology · 2025
   Article
3. Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut-Brain Axis andNeurology international · 2024
   Review
4. Extra-motor cerebral changes and manifestations in primary lateral sclerosis.Brain imaging and behavior · 2021
   Article
5. Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece.International journal of MS care
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 3 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as